ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,141,000 | +16.0% | 781,492 | +12.7% | 0.00% | 0.0% |
| Q4 2016 | $984,000 | -26.7% | 693,191 | -9.6% | 0.00% | 0.0% |
| Q3 2016 | $1,342,000 | -0.1% | 766,688 | -2.4% | 0.00% | 0.0% |
| Q2 2016 | $1,343,000 | -19.5% | 785,139 | -7.4% | 0.00% | 0.0% |
| Q1 2016 | $1,669,000 | +0.8% | 847,433 | -2.8% | 0.00% | 0.0% |
| Q4 2015 | $1,656,000 | -3.4% | 871,676 | -2.9% | 0.00% | 0.0% |
| Q3 2015 | $1,715,000 | -67.3% | 897,855 | -20.6% | 0.00% | -75.0% |
| Q2 2015 | $5,248,000 | -9.0% | 1,131,141 | -14.3% | 0.00% | 0.0% |
| Q1 2015 | $5,770,000 | +42.4% | 1,320,354 | +13.1% | 0.00% | +33.3% |
| Q4 2014 | $4,051,000 | -20.9% | 1,167,331 | -4.5% | 0.00% | -25.0% |
| Q3 2014 | $5,124,000 | -21.4% | 1,222,814 | +9.9% | 0.00% | -20.0% |
| Q2 2014 | $6,519,000 | +3.1% | 1,112,476 | +10.8% | 0.01% | 0.0% |
| Q1 2014 | $6,323,000 | +7.2% | 1,003,648 | -0.5% | 0.01% | +25.0% |
| Q4 2013 | $5,901,000 | – | 1,008,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |